vs

Side-by-side financial comparison of CAPRICOR THERAPEUTICS, INC. (CAPR) and FLEXIBLE SOLUTIONS INTERNATIONAL INC (FSI). Click either name above to swap in a different company.

CAPRICOR THERAPEUTICS, INC. is the larger business by last-quarter revenue ($11.1M vs $9.1M, roughly 1.2× FLEXIBLE SOLUTIONS INTERNATIONAL INC). FLEXIBLE SOLUTIONS INTERNATIONAL INC runs the higher net margin — -5.1% vs -63.9%, a 58.9% gap on every dollar of revenue. On growth, FLEXIBLE SOLUTIONS INTERNATIONAL INC posted the faster year-over-year revenue change (-0.5% vs -7.9%). FLEXIBLE SOLUTIONS INTERNATIONAL INC produced more free cash flow last quarter ($-4.0M vs $-15.3M). Over the past eight quarters, CAPRICOR THERAPEUTICS, INC.'s revenue compounded faster (93.0% CAGR vs -0.6%).

Capricor Therapeutics is a clinical-stage biotechnology company focused on discovering, developing and commercializing innovative biological therapies including cell and gene therapies for rare diseases, cardiovascular disorders and muscular conditions. It primarily operates in the U.S. market, addressing unmet medical needs for patient groups with limited treatment options.

Flexible Solutions International Inc develops and manufactures specialty chemicals for water conservation, energy efficiency, and agricultural use. Core products include water body evaporative reduction solutions, farm crop yield additives, and swimming pool heat retention products, serving customers across North America and global agricultural markets.

CAPR vs FSI — Head-to-Head

Bigger by revenue
CAPR
CAPR
1.2× larger
CAPR
$11.1M
$9.1M
FSI
Growing faster (revenue YoY)
FSI
FSI
+7.4% gap
FSI
-0.5%
-7.9%
CAPR
Higher net margin
FSI
FSI
58.9% more per $
FSI
-5.1%
-63.9%
CAPR
More free cash flow
FSI
FSI
$11.2M more FCF
FSI
$-4.0M
$-15.3M
CAPR
Faster 2-yr revenue CAGR
CAPR
CAPR
Annualised
CAPR
93.0%
-0.6%
FSI

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
CAPR
CAPR
FSI
FSI
Revenue
$11.1M
$9.1M
Net Profit
$-7.1M
$-460.9K
Gross Margin
29.4%
Operating Margin
-69.1%
11.6%
Net Margin
-63.9%
-5.1%
Revenue YoY
-7.9%
-0.5%
Net Profit YoY
-833.8%
-167.8%
EPS (diluted)
$-0.11
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAPR
CAPR
FSI
FSI
Q4 25
$9.1M
Q3 25
$10.6M
Q2 25
$11.4M
Q1 25
$7.5M
Q4 24
$11.1M
$9.2M
Q3 24
$2.3M
$9.3M
Q2 24
$4.0M
$10.5M
Q1 24
$4.9M
$9.2M
Net Profit
CAPR
CAPR
FSI
FSI
Q4 25
$-460.9K
Q3 25
$-503.4K
Q2 25
$2.0M
Q1 25
$-277.7K
Q4 24
$-7.1M
$679.6K
Q3 24
$-12.6M
$611.9K
Q2 24
$-11.0M
$1.3M
Q1 24
$-9.8M
$457.2K
Gross Margin
CAPR
CAPR
FSI
FSI
Q4 25
29.4%
Q3 25
23.9%
Q2 25
47.4%
Q1 25
26.1%
Q4 24
29.2%
Q3 24
40.9%
Q2 24
37.4%
Q1 24
30.6%
Operating Margin
CAPR
CAPR
FSI
FSI
Q4 25
11.6%
Q3 25
2.9%
Q2 25
29.0%
Q1 25
-0.9%
Q4 24
-69.1%
9.4%
Q3 24
-575.2%
20.5%
Q2 24
-291.9%
18.7%
Q1 24
-209.2%
8.3%
Net Margin
CAPR
CAPR
FSI
FSI
Q4 25
-5.1%
Q3 25
-4.8%
Q2 25
17.8%
Q1 25
-3.7%
Q4 24
-63.9%
7.4%
Q3 24
-555.2%
6.6%
Q2 24
-277.0%
12.3%
Q1 24
-199.6%
5.0%
EPS (diluted)
CAPR
CAPR
FSI
FSI
Q4 25
$-0.03
Q3 25
$-0.04
Q2 25
$0.15
Q1 25
$-0.02
Q4 24
$-0.11
$0.05
Q3 24
$-0.38
$0.05
Q2 24
$-0.35
$0.10
Q1 24
$-0.31
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAPR
CAPR
FSI
FSI
Cash + ST InvestmentsLiquidity on hand
$151.5M
Total DebtLower is stronger
$4.4M
Stockholders' EquityBook value
$145.5M
$38.9M
Total Assets
$170.5M
$61.8M
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAPR
CAPR
FSI
FSI
Q4 25
Q3 25
Q2 25
$10.0M
Q1 25
$11.0M
Q4 24
$151.5M
$10.0M
Q3 24
$85.0M
$13.0M
Q2 24
$29.5M
$9.2M
Q1 24
$39.9M
$8.3M
Total Debt
CAPR
CAPR
FSI
FSI
Q4 25
$4.4M
Q3 25
$7.1M
Q2 25
$7.5M
Q1 25
$8.1M
Q4 24
$8.8M
Q3 24
$9.4M
Q2 24
$8.3M
Q1 24
$8.0M
Stockholders' Equity
CAPR
CAPR
FSI
FSI
Q4 25
$38.9M
Q3 25
$39.0M
Q2 25
$39.4M
Q1 25
$38.4M
Q4 24
$145.5M
$38.0M
Q3 24
$68.3M
$36.9M
Q2 24
$11.5M
$36.2M
Q1 24
$18.4M
$36.0M
Total Assets
CAPR
CAPR
FSI
FSI
Q4 25
$61.8M
Q3 25
$58.4M
Q2 25
$58.2M
Q1 25
$61.7M
Q4 24
$170.5M
$60.0M
Q3 24
$93.0M
$57.8M
Q2 24
$38.3M
$56.3M
Q1 24
$49.4M
$57.6M
Debt / Equity
CAPR
CAPR
FSI
FSI
Q4 25
0.11×
Q3 25
0.18×
Q2 25
0.19×
Q1 25
0.21×
Q4 24
0.23×
Q3 24
0.25×
Q2 24
0.23×
Q1 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAPR
CAPR
FSI
FSI
Operating Cash FlowLast quarter
$-14.8M
$-3.0M
Free Cash FlowOCF − Capex
$-15.3M
$-4.0M
FCF MarginFCF / Revenue
-137.3%
-44.3%
Capex IntensityCapex / Revenue
4.4%
11.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.2M
$-591.7K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAPR
CAPR
FSI
FSI
Q4 25
$-3.0M
Q3 25
$2.0M
Q2 25
$5.3M
Q1 25
$-544.3K
Q4 24
$-14.8M
$-2.2M
Q3 24
$-11.6M
$2.5M
Q2 24
$-12.3M
$5.9M
Q1 24
$-1.3M
$-604.8K
Free Cash Flow
CAPR
CAPR
FSI
FSI
Q4 25
$-4.0M
Q3 25
$39.4K
Q2 25
$4.3M
Q1 25
$-898.4K
Q4 24
$-15.3M
$-4.3M
Q3 24
$-11.7M
$1.3M
Q2 24
$-12.3M
$4.7M
Q1 24
$-1.9M
$-1.1M
FCF Margin
CAPR
CAPR
FSI
FSI
Q4 25
-44.3%
Q3 25
0.4%
Q2 25
37.9%
Q1 25
-12.0%
Q4 24
-137.3%
-47.0%
Q3 24
-515.2%
13.6%
Q2 24
-310.9%
44.9%
Q1 24
-38.3%
-11.7%
Capex Intensity
CAPR
CAPR
FSI
FSI
Q4 25
11.7%
Q3 25
18.7%
Q2 25
8.6%
Q1 25
4.7%
Q4 24
4.4%
22.8%
Q3 24
0.4%
13.0%
Q2 24
1.5%
11.3%
Q1 24
12.4%
5.2%
Cash Conversion
CAPR
CAPR
FSI
FSI
Q4 25
Q3 25
Q2 25
2.60×
Q1 25
Q4 24
-3.27×
Q3 24
4.05×
Q2 24
4.59×
Q1 24
-1.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons